These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 9857979

  • 1. Direct determination of dopamine D4 receptors in normal and schizophrenic postmortem brain tissue: a [3H]NGD-94-1 study.
    Lahti RA, Roberts RC, Cochrane EV, Primus RJ, Gallager DW, Conley RR, Tamminga CA.
    Mol Psychiatry; 1998 Nov; 3(6):528-33. PubMed ID: 9857979
    [Abstract] [Full Text] [Related]

  • 2. II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94-1.
    Primus RJ, Thurkauf A, Xu J, Yevich E, McInerney S, Shaw K, Tallman JF, Gallagher DW.
    J Pharmacol Exp Ther; 1997 Aug; 282(2):1020-7. PubMed ID: 9262371
    [Abstract] [Full Text] [Related]

  • 3. I. NGD 94-1: identification of a novel, high-affinity antagonist at the human dopamine D4 receptor.
    Tallman JF, Primus RJ, Brodbeck R, Cornfield L, Meade R, Woodruff K, Ross P, Thurkauf A, Gallager DW.
    J Pharmacol Exp Ther; 1997 Aug; 282(2):1011-9. PubMed ID: 9262370
    [Abstract] [Full Text] [Related]

  • 4. [3H]Neurotensin receptor densities in human postmortem brain tissue obtained from normal and schizophrenic persons. An autoradiographic study.
    Lahti RA, Cochrane EV, Roberts RC, Conley RR, Tamminga CA.
    J Neural Transm (Vienna); 1998 Aug; 105(4-5):507-16. PubMed ID: 9720978
    [Abstract] [Full Text] [Related]

  • 5. D2-type dopamine receptors in postmortem human brain sections from normal and schizophrenic subjects.
    Lahti RA, Roberts RC, Conley RR, Cochrane EV, Mutin A, Tamminga CA.
    Neuroreport; 1996 Aug 12; 7(12):1945-8. PubMed ID: 8905699
    [Abstract] [Full Text] [Related]

  • 6. Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study.
    Gurevich EV, Bordelon Y, Shapiro RM, Arnold SE, Gur RE, Joyce JN.
    Arch Gen Psychiatry; 1997 Mar 12; 54(3):225-32. PubMed ID: 9075463
    [Abstract] [Full Text] [Related]

  • 7. Are striatal dopamine D4 receptors increased in schizophrenia?
    Reynolds GP, Mason SL.
    J Neurochem; 1994 Oct 12; 63(4):1576-7. PubMed ID: 7931313
    [Abstract] [Full Text] [Related]

  • 8. The binding of both [3H]nemonapride and [3H]raclopride is increased in schizophrenia.
    Marzella PL, Hill C, Keks N, Singh B, Copolov D.
    Biol Psychiatry; 1997 Oct 15; 42(8):648-54. PubMed ID: 9325557
    [Abstract] [Full Text] [Related]

  • 9. Regional distribution of dopamine D4 receptors in rat forebrain.
    Tarazi FI, Kula NS, Baldessarini RJ.
    Neuroreport; 1997 Nov 10; 8(16):3423-6. PubMed ID: 9427299
    [Abstract] [Full Text] [Related]

  • 10. Review the role of dopamine D4 receptors in schizophrenia and antipsychotic action.
    Sanyal S, Van Tol HH.
    J Psychiatr Res; 1997 Nov 10; 31(2):219-32. PubMed ID: 9278187
    [Abstract] [Full Text] [Related]

  • 11. Increased [3H] raclopride binding sites in postmortem brains from schizophrenic violent suicide victims.
    Ruiz J, Gabilondo AM, Meana JJ, García-Sevilla JA.
    Psychopharmacology (Berl); 1992 Nov 10; 109(4):410-4. PubMed ID: 1365855
    [Abstract] [Full Text] [Related]

  • 12. Dopamine D4 receptors: a new opportunity for research on schizophrenia.
    Liégeois J, Eyrolles L, Bruhwyler J, Delarge J.
    Curr Med Chem; 1998 Apr 10; 5(2):77-100. PubMed ID: 9481035
    [Abstract] [Full Text] [Related]

  • 13. Dopamine D4 receptors and effects of guanine nucleotides on [3H]raclopride binding in postmortem caudate nucleus of subjects with schizophrenia or major depression.
    Sumiyoshi T, Stockmeier CA, Overholser JC, Thompson PA, Meltzer HY.
    Brain Res; 1995 May 29; 681(1-2):109-16. PubMed ID: 7552267
    [Abstract] [Full Text] [Related]

  • 14. Quantitative autoradiography of dopamine-D1 receptors, D2 receptors, and dopamine uptake sites in postmortem striatal specimens from schizophrenic patients.
    Knable MB, Hyde TM, Herman MM, Carter JM, Bigelow L, Kleinman JE.
    Biol Psychiatry; 1994 Dec 15; 36(12):827-35. PubMed ID: 7893846
    [Abstract] [Full Text] [Related]

  • 15. NGD 94-1: a specific dopamine-4-receptor antagonist.
    Tallman JF.
    Adv Pharmacol; 1998 Dec 15; 42():490-2. PubMed ID: 9327946
    [No Abstract] [Full Text] [Related]

  • 16. Disrupted pattern of D2 dopamine receptors in the temporal lobe in schizophrenia. A postmortem study.
    Goldsmith SK, Shapiro RM, Joyce JN.
    Arch Gen Psychiatry; 1997 Jul 15; 54(7):649-58. PubMed ID: 9236549
    [Abstract] [Full Text] [Related]

  • 17. NGD 94-1 as an agonist at human recombinant dopamine D4.4 receptors expressed in HEK293 cells.
    Gazi L, Sommer B, Nozulak J, Schoeffter P.
    Eur J Pharmacol; 1999 May 21; 372(3):R9-10. PubMed ID: 10395031
    [Abstract] [Full Text] [Related]

  • 18. Autoradiographic localization of dopamine D2-like receptors in the rat adrenal gland.
    Amenta F, Ricci A.
    Clin Exp Hypertens; 1995 May 21; 17(4):669-88. PubMed ID: 7795580
    [Abstract] [Full Text] [Related]

  • 19. Differential labeling of dopamine and sigma sites by [3H]nemonapride and [3H]raclopride in postmortem human brains.
    Tang SW, Helmeste DM, Fang H, Li M, Vu R, Bunney W, Potkin S, Jones EG.
    Brain Res; 1997 Aug 08; 765(1):7-12. PubMed ID: 9310388
    [Abstract] [Full Text] [Related]

  • 20. Measurement of dopamine D2-like receptors in postmortem CNS and pituitary: differential regional changes in schizophrenia.
    Dean B, Pavey G, Scarr E, Goeringer K, Copolov DL.
    Life Sci; 2004 May 07; 74(25):3115-31. PubMed ID: 15081577
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.